恒立实业(000622) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥54,433,726.27, representing an increase of 1,581.77% compared to the same period last year[4]. - The net profit attributable to shareholders for Q3 2024 was -¥4,583,170.77, a decrease of 26.43% year-on-year[4]. - The company's basic earnings per share for Q3 2024 was -¥0.0108, a decline of 26.43% year-on-year[4]. - The net loss attributable to the parent company increased to CNY -456,165,204.53 from CNY -439,950,277.21, indicating a worsening financial position[18]. - The net profit for Q3 2024 was -16,214,927.32 CNY, compared to -5,471,915.54 CNY in Q3 2023, indicating a significant increase in losses[20]. - Operating profit for Q3 2024 was -16,223,512.14 CNY, compared to -5,469,569.21 CNY in the same period last year[20]. - The total comprehensive income for Q3 2024 was -16,214,927.32 CNY, compared to -5,471,915.54 CNY in Q3 2023[21]. Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period was -¥19,954,014.62, showing an improvement of 52.35% compared to the previous year[4]. - Cash flow from operating activities showed a net outflow of -19,954,014.62 CNY, an improvement from -41,879,958.65 CNY in the previous year[23]. - Cash and cash equivalents at the end of Q3 2024 were 5,594,400.98 CNY, a decrease from 15,670,419.96 CNY at the end of Q3 2023[23]. - The company's cash and cash equivalents increased by 72.77% to ¥7,008.79 million due to investments in subsidiaries and increased operational expenses[8]. - The company's cash and cash equivalents increased to CNY 70,087,877.48 from CNY 40,567,321.28, representing a growth of 72.9%[15]. Assets and Liabilities - Total assets at the end of the reporting period were ¥481,526,976.76, reflecting a growth of 21.62% from the end of the previous year[4]. - The total assets increased by 20.85% to RMB 7,473.31 million, up from RMB 6,183.88 million, indicating strong asset growth[9]. - The total assets as of September 30, 2024, amounted to CNY 481,526,976.76, compared to CNY 395,942,323.92 at the beginning of the year, indicating a growth of 21.6%[17]. - The total liabilities increased to CNY 307,875,226.89 from CNY 206,075,646.73, reflecting a rise of 49.3%[18]. Inventory and Receivables - Inventory levels rose significantly by 238.82% to ¥4,744.58 million, primarily due to increases in stock at subsidiaries[8]. - The company reported a decrease in accounts receivable by 8.63% to ¥5,202.12 million, indicating improved collection efforts[8]. - Accounts receivable decreased to CNY 52,021,193.28 from CNY 56,935,706.00, a decline of 8.1%[16]. Operating Costs and Expenses - Operating costs rose to RMB 6,925.84 million, reflecting a significant increase of 34.54% from RMB 5,147.75 million, primarily due to a decline in gross margin at the subsidiary's component company[9]. - The total operating costs for Q3 2024 were CNY 87,318,973.79, up from CNY 64,913,747.31, reflecting a significant increase in costs[19]. - The company incurred financial expenses of 1,319,378.59 CNY in Q3 2024, compared to a financial income of 902,889.96 CNY in Q3 2023[20]. - Research and development expenses for Q3 2024 were 1,709,585.49 CNY, down from 1,958,154.04 CNY in Q3 2023[20]. - The company reported a decrease in sales expenses to 1,171,699.40 CNY in Q3 2024 from 1,635,112.07 CNY in Q3 2023[20]. Shareholder Information and Corporate Changes - The company has a total of 18,480 common shareholders as of the report date, with the largest shareholder holding 17.87% of the shares[11]. - The company is undergoing a change in control, with the largest shareholder transferring 76 million shares (17.87% of total shares) to a new entity, which will alter the actual controller of the company[13]. Other Income and Subsidies - The company received government subsidies totaling ¥131,228.54 in Q3 2024, contributing to its non-operating income[6]. - The company reported a significant increase in other income, which rose by 131.53% to RMB 30.29 million, mainly due to increased fiscal subsidies[10].